NEVVI Medicare utilization intelligence
or

← back

Provider profile

ROQUE, TAMMY MD

Medical Oncology · NPI 1376581330 · SHERMAN, TX

1
Groups
70
Codes · 2024
162,335
Disclosed services

ROQUE, TAMMY is a Medical Oncology in SHERMAN, TX, a member of 1 medical group, who billed 70 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

162,335
disclosed services
70
codes billed to Medicare Part B
Prior year · CY2023 47,208 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9299 Injection, nivolumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1756 Injection, iron sucrose, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J9171 Injection, docetaxel, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
Q5107 Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
J9190 Injection, fluorouracil, 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J3489 Injection, zoledronic acid, 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9045 Injection, carboplatin, 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
96372 Injection of drug or substance under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
96523 Irrigation of implanted venous access drug delivery device
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
J3490 Unclassified drugs
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
71260 Ct scan of chest with contrast
83735 Magnesium level
83615 Lactate dehydrogenase (enzyme) level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J3475 Injection, magnesium sulfate, per 500 mg
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
74177 Ct scan of abdomen and pelvis with contrast
85055 Reticulated (young) platelet measurement
J7030 Infusion, normal saline solution , 1000 cc
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
71250 Ct scan of chest without contrast
81001 Manual urinalysis test with examination using microscope, automated
99195 Drawing of blood for a medical problem
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
96377 Application of on-body injector for under skin injection
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
74176 Ct scan of abdomen and pelvis without contrast
84153 Psa (prostate specific antigen) measurement, total

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.